RxDoctor Payments Data

Sara Newell

Rheumatology · Tulsa, OKNPI 1023017878

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 54.3% of the total. Reporting peaked in 2021 at $856 and has fallen 83.6% since, to $141 in 2022. That places this record below the midpoint for rheumatology clinicians in OK, where the typical reported total is $4,359.

$1,996in general payments, 2019–2025

Across 151 payments — averaging $13.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$197
  • Pfizer$136
  • GSK$121
  • Novartis$100
  • E.r. Squibb & Sons, L.L.C.$87
  • plus $272 from 9 others

What the payments were for

  • Food & beverage$1,97799%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,996 in reported general payments places this provider in the 40th percentile of 67 rheumatology providers in Oklahoma.

See all rheumatology providers in Oklahoma

Other rheumatology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →